Good morning :)
$
₹
IDEXX Laboratories Inc

IDEXX Laboratories Inc

IDXX

NASDAQ
Asset Logo

IDEXX Laboratories Inc

IDXX

NASDAQ
$671.093.92% (-27.45)
$
₹
$671.093.92% (-27.45)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Diagnostics & Research

Large Cap

With a market cap of $53.0B the stock is ranked 312

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

45.25
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

32.81
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$14.85
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

3.67
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

25.36%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 14 analysts reports

Buy
9 analysts
Hold
4 analysts
Sell
1 analyst

Price Upside

+1.05%

Earnings Growth

+14.24%

Rev. Growth

+10.53%

See Detailed Forecast

Company Profile

Company Profile

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Abbott Laboratories
ABT
Abbott Laboratories
P/E Ratio
40.97
40.97
1Y Return
7.25%
7.25%
Buy Reco %
82.14
82.14
Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
38.09
38.09
1Y Return
10.7%
10.7%
Buy Reco %
83.33
83.33
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
53.29
53.29
1Y Return
12.11%
12.11%
Buy Reco %
76.47
76.47
Medtronic PLC
MDT
Medtronic PLC
P/E Ratio
24.41
24.41
1Y Return
15.97%
15.97%
Buy Reco %
66.66
66.66
Stryker Corporation
SYK
Stryker Corporation
P/E Ratio
32.68
32.68
1Y Return
6.31%
6.31%
Buy Reco %
76.66
76.66
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Lower price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 1.05% growth, versus a trailing 3-year CAGR of 18.20%.

2026
Current$698.55Baseline
Analyst Target - 1 year
Target$705.92+1.05%

All values in $

202220232024202520262027$469.50$571.84$674.17Target+1.05%
2026
Current$698.55Baseline
Analyst Target - 1 year
Target$705.92+1.05%

All values in $

Revenue Forecast

Revenue Forecast

Higher revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 10.53% growth, versus a trailing 3-year CAGR of 8.52%.

2025
Current$4.30Baseline
Forecast for Dec 2026
High$4.77+10.9%
Average$4.75+10.53%
Low$4.75+10.39%

All values in $ Billion

2021202220232024202520263.213.363.663.894.30Low+10.39%Average+10.53%High+10.9%
2025
Current$4.30Baseline
Forecast for Dec 2026
High$4.77+10.9%
Average$4.75+10.53%
Low$4.75+10.39%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

Lower earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 14.24% growth, versus a trailing 3-year CAGR of 17.63%.

2025
Current$13.07Baseline
Forecast for Dec 2026
High$15.09+15.46%
Average$14.93+14.24%
Low$14.6+11.71%

All values in $

2021202220232024202520268.618.0310.0711.2513.07Low+11.71%Average+14.24%High+15.46%
2025
Current$13.07Baseline
Forecast for Dec 2026
High$15.09+15.46%
Average$14.93+14.24%
Low$14.6+11.71%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

1
0.2
1.1
0.2
1.2
0.3
1.2
0.3
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Revenue
Net Income
Financial YearQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Total Revenue10.970.950.991.101.101.091.141.211.21
Net Income0.200.230.210.240.290.270.240.270.330.31
Net Profit Margin20.25%23.86%22.65%24.30%26.49%24.84%22.75%24.40%27.81%26.11%
See CostsAll values in $ Billion

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareDiagnostics & Research

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
IDEXX Laboratories Inc 45.2532.813.67
Abbott Laboratories40.973.721.57
Danaher Corporation38.092.981.29
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare IDXX with any stock or ETF
Compare IDXX with any stock or ETF
Comparing from
IDXX
ABT
DHR
Loading...

Frequently asked questions

  1. IDEXX Laboratories Inc (IDXX) share price today is $671.09 as of November 6, 2026 at 2:29 AM IST. The stock touched a day high of $703.04 and a day low of $664.99.

  2. IDEXX Laboratories Inc stock trades on NASDAQ under the ticker symbol IDXX.

  3. IDEXX Laboratories Inc's market capitalization is $53.01B as of November 6, 2026 at 2:29 AM IST.

  4. IDEXX Laboratories Inc's price-to-earnings (P/E) ratio is 45.25 as of November 5, 2026.

  5. IDEXX Laboratories Inc's price-to-book (P/B) ratio is 32.81 as of November 5, 2026.

  6. Yes, You can buy IDEXX Laboratories Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy IDEXX Laboratories Inc shares in three steps: 1. Search IDEXX Laboratories Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since IDEXX Laboratories Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in IDEXX Laboratories Inc (IDXX) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.0149 shares at the current price of $671.09.

Loading...